E-LIB Suche - Ergebnisse für: Gorry, C

1

P5 An Update on Calcitonin Gene-Related Peptide Monoclonal ..:

Finnigan, K. ; Smith, A. ; Clarke, S...
Value in Health. 26 (2023) 12 - p. S2 , 2023

Link: https://doi.org/10.1016/..

2

HPR14 Applications for Tafamidis (Vyndaqel®) Under a Manage..:

Lucey, S. ; Gorry, C. ; Clarke, S..
Value in Health. 26 (2023) 12 - p. S257 , 2023

Link: https://doi.org/10.1016/..

3

HPR2 Baseline Characteristics of Patients Applying for Reim..:

Gorry, C. ; Daly, M. ; Doran, S....
Value in Health. 26 (2023) 12 - p. S255 , 2023

Link: https://doi.org/10.1016/..

4

PT20 Applications for Tolvaptan (JINARC®) Under a Managed A..:

Kelly, L. ; Finnigan, K. ; Clarke, S...
Value in Health. 26 (2023) 12 - p. S292 , 2023

Link: https://doi.org/10.1016/..

5

HPR67 Utilisation of Intermittent and Real-Time Continuous ..:

Gorry, C. ; Smith, A. ; Doran, S...
Value in Health. 26 (2023) 12 - p. S265 , 2023

Link: https://doi.org/10.1016/..

6

HPR24 Utilisation and Expenditure on Blood Glucose Test Str..:

Doran, S. ; Clarke, S. ; Smith, A...
Value in Health. 26 (2023) 12 - p. S258 , 2023

Link: https://doi.org/10.1016/..

7

POSC58 Budget Impact of Pembrolizumab for Untreated or Unre..:

Flynn, C ; McCullagh, L ; Barry, M.
Value in Health. 25 (2022) 1 - p. S97 , 2022

Link: https://doi.org/10.1016/..

8

POSA141 Cost Effectiveness Analysis of Pembrolizumab Monoth..:

Chu, R ; Vegas, A ; Gorry, C.
Value in Health. 25 (2022) 1 - p. S61 , 2022

Link: https://doi.org/10.1016/..

9

POSA411 Real World Outcomes of First Line Pembrolizumab Mon..:

Chu, R ; Vegas, A ; Gorry, C.
Value in Health. 25 (2022) 1 - p. S253 , 2022

Link: https://doi.org/10.1016/..

10

Integrating intravenous frusemide treatment into the commun..:

Caples, N ; Gorry, C ; Hennessy, A...
European Heart Journal. 41 (2020) Supplement_2 - p. , 2020

Link: https://doi.org/10.1093/..

11

PCN240 POTENTIAL BUDGET IMPACT OF ADJUVANT TREATMENTS FOR S..:

Gorry, C. ; McCullagh, L. ; Barry, M.
Value in Health. 22 (2019) - p. S482 , 2019

Link: https://doi.org/10.1016/..

12

PNS349 DEVELOPMENT OF PLAIN ENGLISH SUMMARIES OF HEALTH TEC..:

Gorry, C. ; Hanevy, A. ; Tilson, L..
Value in Health. 22 (2019) - p. S823 , 2019

Link: https://doi.org/10.1016/..

13

PCN73 ECONOMIC EVALUATION OF TARGETED TREATMENTS FOR BRAFV6..:

Gorry, C. ; Leahy, J. ; Lamrock, F...
Value in Health. 22 (2019) - p. S449 , 2019

Link: https://doi.org/10.1016/..

14

PCN184 ECONOMIC EVALUATION OF CHECKPOINT INHIBITORS FOR THE..:

Gorry, C. ; Leahy, J. ; Lamrock, F...
Value in Health. 22 (2019) - p. S471-S472 , 2019

Link: https://doi.org/10.1016/..

15

PCN284 PRESCRIBING TRENDS ACROSS EPIDERMAL GROWTH FACTOR RE..:

Gorry, C. ; Connolly, E. ; Trela-Larsen, L..
Value in Health. 22 (2019) - p. S491 , 2019

Link: https://doi.org/10.1016/..